Geographically, the North American region held the largest share of the chronic pain treatment market in 2020, and it is expected to maintain its position in the forecast period as well.The global chronic pain treatment market revenue stood at $80,766.6 million in 2020, and it is predicted to rise at a CAGR of 7.2% from 2020 to 2030. According to the estimates of the market research company, P&S Intelligence, the market will reach a value of $162,175.2 million by 2030. The market is being propelled by the increasing government support being provided for the adoption of chronic pain treatment drugs, surging population of geriatric people, and rising incidence of chronic health conditions across the world.
As per the World Health Organization, the share of the population of people aged over 60 years will double from 12% to 22% from 2015 to 2020. Moreover, the prevalence of chronic pain among geriatric people in nursing homes is considerably high, and has emerged as a serious issue for care facilities. Thus, in order to treat this condition, the demand for occupational therapies, such as those involving assistive devices and joint protection education, pharmacological, and non-pharmacological (physical therapies, such as exercises, patellar taping or foot orthotics for knee osteoarthritis), is growing rapidly across the globe.
Besides the aforementioned factors, the growing prevalence of various chronic diseases, such as fibromyalgia, autoimmune diseases (rheumatoid arthritis), sickle-cell anaemia, cancer, and osteoarthritis, is also propelling the demand for chronic pain treatment products, especially in low- and middle-income countries. According to the World Health Organization (WHO), cancer was responsible for the death of around 10 million people in 2020. Because of the rising incidence of chronic diseases, the demand for many treatment options, such as physiotherapy, medication, and psychological therapy, is booming globally.
Browse detailed report on Chronic Pain Treatment Market Analysis and Growth Forecast to 2030
Depending on product, the chronic pain treatment market is divided into devices and drugs. Between these, the drugs category contributed the highest revenue to the market in the past. This was primarily because of the booming geriatric population, surging number of surgeries, and rising prevalence of chronic pain, such as severe headache, lower back pain, facial pain, or migraine. The market is also classified into chronic back pain, migraine, neuropathic pain, arthritis pain, fibromyalgia, and cancer pain, on the basis of indication.
Amongst these, the cancer pain category is predicted to demonstrate the fastest growth in the coming years, on account of the rising incidence of cancer. Moreover, around 70% of the deaths from cancer are reported in low- and middle-income countries, which is pushing up the requirement for drugs and devices, including opioids. Lung, prostate, colon and rectum, stomach, skin, and breast cancers are the most prevalent types of cancers across the globe.
Globally, North America contributed the highest revenue to the chronic pain treatment market in the past, and this trend is predicted to continue in the coming years as well. This is ascribed to the existence of advanced healthcare infrastructure and many drug producers in the region. Whereas, Asia-Pacific is predicted to be the fastest-growing region in the market in the years to come, on account of the existence of a large patient pool and surging healthcare expenditure in the region.
Get the sample pages of this report at: https://www.psmarketresearch.com/market-analysis/chronic-pain-treatment-market/report-sample
Hence, it can be safely said that the demand for chronic pain treatment drugs will shoot up all over the world in the coming years, primarily because of the rising incidence of chronic pain and health conditions and surging population of geriatric people.
Chronic Pain Treatment Market Size Breakdown by Segment
By Product
- Drugs
- Opioids
- Non-steroidal anti-inflammatory drugs (NSAIDs)
- Anticonvulsants
- Antidepressants
- Others
- Devices
- Neurostimulation devices
- Spinal cord stimulation (SCS) devices
- Transcutaneous electrical nerve stimulation (TENS) devices
- Others
- Analgesic infusion pumps
- Ablation devices
- Radiofrequency ablation devices
- Cryoablation devices
By Indication
- Neuropathic Pain
- Arthritis Pain
- Chronic Back Pain
- Cancer Pain
- Migraine
- Fibromyalgia
By Application
- Musculoskeletal
- Neuropathy
- Oncology
By Distribution Channel
- Direct
- Indirect
By End User
- Hospitals
- Clinics
- Nursing Homes
- Research Centers & Universities
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Netherlands
- Russia
- Sweden
- Switzerland
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Middle East and Africa
- Saudi Arabia
- South Africa
Browse Other Related Reports
Regenerative Medicine Market Report - Across the globe, the regenerative medicine market registered the highest growth in North America between 2014 and 2019 and this trend is likely to continue in the forthcoming years as well. This is credited to the surging number of stem cell research institutes, the soaring healthcare expenditure, the increasing number of stem cell banks, and rapid technological advancements and innovations in biomaterial scaffolds for advancing tissue engineering in the region.
Dermatology Drugs Market Report - Geographically, Asia-Pacific is projected to record the highest CAGR during the forecast period. This can be due to the surging disposable income, increasing prevalence of skin diseases, and rising healthcare spending in regional countries. For example, as per the World Bank, China spent 5.15% of its gross domestic product (GDP) on healthcare in 2017.
Media Contact
Company Name: P&S Intelligence
Contact Person: Abhishek
Email: Send Email
Phone: +918887787886
Address:Noida Sector 2
City: Noida
State: UP
Country: India
Website: https://www.psmarketresearch.com/market-analysis/chronic-pain-treatment-market
